miR-539-5p inhibits experimental choroidal neovascularization by targeting CXCR7.
Feng Y, Wang J, Yuan Y, Zhang X, Shen M, Yuan F.
Feng Y, et al. Among authors: yuan f, yuan y.
FASEB J. 2018 Mar;32(3):1626-1639. doi: 10.1096/fj.201700640R. Epub 2018 Jan 3.
FASEB J. 2018.
PMID: 29146732
These findings suggest that the manipulation of miR-539-5p/CXCR7 levels may have important therapeutic implications in CNV-associated diseases.-Feng, Y., Wang, J., Yuan, Y., Zhang, X., Shen, M., Yuan, F. miR-539-5p inhibits experimental choroidal neova …
These findings suggest that the manipulation of miR-539-5p/CXCR7 levels may have important therapeutic implications in CNV-associated diseas …